BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/24/2023 11:14:10 AM | Browse: 332 | Download: 863
 |
Received |
|
2022-10-31 15:07 |
 |
Peer-Review Started |
|
2022-10-31 15:08 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-02-02 08:00 |
 |
Revised |
|
2023-02-17 15:06 |
 |
Second Decision |
|
2023-04-07 01:06 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-04-07 03:30 |
 |
Articles in Press |
|
2023-04-07 03:30 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-04-15 06:05 |
 |
Publish the Manuscript Online |
|
2023-04-24 11:14 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups
|
Manuscript Source |
Invited Manuscript |
All Author List |
George D Liatsos |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
George D Liatsos, MD, PhD, Chief Doctor, Department of Internal Medicine, Hippokration General Hospital, Vassilisis Sofias 114, TK 11527, Athens 11527, Attiki, Greece. geoliatsos@yahoo.gr |
Key Words |
COVID-19; Liver injury; Cytokine storm; Endotheliopathy; Immuno-thromboinflammation; Direct hepatocyte injury |
Core Tip |
Following respiratory system, liver is the second most involved organ in coronavirus disease 2019 (COVID-19). Besides the well-observed cholangiocyte tropism, typical severe acute respiratory distress syndrome corona virus-2 (SARS-CoV-2) Lesions indicated by ultrastructural and histological evidence, identification of replicating SARS-CoV-2, S and nucleocapsid proteins RNAs within hepatocytes, as well as intrahepatic virus observation by electron microscopy and in-situ hybridization, converge to the conclusion that SARS-CoV-2 may also be hepatotropic. Most prevalent mechanisms of COVID-19-related liver injury are hypercytokinemia with “bystander hepatitis”, cytokine storm syndrome with subsequent oxidative stress, endotheliopathy and immuno-thromboinflammation. Depending on the grade of their abnormalities, increased serum aspartate aminotransferase, (mostly peak) alanine aminotransferase, alkaline phosphatase, total bilirubin, inflammatory markers (C-reactive protein, ferritin, interleukin-6, -10) and decreased albumin levels are independent discriminators of COVID-19 severity and mortality. Age, male gender, chronic liver disease, liver cirrhosis, obesity, diabetes, and non-alcoholic fatty liver disease are independent prognostic factors of unfavorable COVID-19 outcomes. |
Publish Date |
2023-04-24 11:14 |
Citation |
Liatsos GD. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups. World J Gastroenterol 2023; 29(16): 2397-2432 |
URL |
https://www.wjgnet.com/1007-9327/full/v29/i16/2397.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v29.i16.2397 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345